Shattuck Labs

Shattuck Labs EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Shattuck Labs (STTK) as of Oct 18, 2026 is -51.51 M USD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -80.57 M USD — a change of -36.07% (higher).

EBITDA

-51.51 MUSD

YoY

-36.07%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Shattuck Labs is 2025 -51.51 M USD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Shattuck Labs was 2024 -80.57 M USD. It decreases by -36.07% higher compared to the previous year.

The Shattuck Labs EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
-5.72 M USD
Jan 1, 2019
-25.07 M USD
Jan 1, 2020
-36.93 M USD
Jan 1, 2021
-45.27 M USD
Jan 1, 2022
-103.33 M USD
Jan 1, 2023
-91.96 M USD
Jan 1, 2024
-80.57 M USD
Jan 1, 2025
-51.51 M USD
The Shattuck Labs EBITDA history
YEAREBITDAYoY
-51.51 MUSD-36.07%
-80.57 MUSD-12.39%
-91.96 MUSD-11.01%
-103.33 MUSD+128.26%
-45.27 MUSD+22.58%
-36.93 MUSD+47.33%
-25.07 MUSD+338.00%
-5.72 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Shattuck Labs Stock analysis

What does Shattuck Labs do? Shattuck Labs Inc, headquartered in Austin, Texas, develops dual-sided fusion proteins for treating cancer and autoimmune diseases. The company, listed on October 9, 2020, focuses on bi-functional fusion proteins as a new class of biologic medicine. Its lead candidate, SL-172154, targets CD47/SIRPa and CD40 pathways in ongoing Phase I trials for ovarian cancer and hematologic malignancies. Shattuck also advances a Gamma Delta T Cell Engager platform for cancer therapy. With 40 employees, it operates in the Health Care sector. Shattuck Labs is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Shattuck Labs stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Shattuck Labs is -51.51 M USD in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Shattuck Labs changed from -80.57 M USD to -51.51 M USD, representing a -36.07% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Shattuck Labs since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Shattuck Labs historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Shattuck Labs

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Shattuck Labs